Jane Street’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-152,958
| Closed | -$9.83M | – | 12175 |
|
|
2026
Q1 | $8.62M | Sell |
152,958
-373,329
| -71% | -$24.3M | ﹤0.01% | 2725 |
|
|
2025
Q4 | $42.2M | Buy |
526,287
+242,544
| +85% | +$16.3M | 0.01% | 1048 |
|
|
2025
Q3 | $13.8M | Buy |
283,743
+267,137
| +1,609% | +$16.5M | ﹤0.01% | 2029 |
|
|
2025
Q2 | $1.24M | Sell |
16,606
-153,351
| -90% | -$10.2M | ﹤0.01% | 5219 |
|
|
2025
Q1 | $10.8M | Buy |
169,957
+134,118
| +374% | +$9.12M | ﹤0.01% | 1896 |
|
|
2024
Q4 | $2.8M | Buy |
35,839
+3,094
| +9% | +$249K | ﹤0.01% | 3569 |
|
|
2024
Q3 | $2.63M | Sell |
32,745
-141,041
| -81% | -$11.4M | ﹤0.01% | 3949 |
|
|
2024
Q2 | $14.4M | Buy |
173,786
+144,948
| +503% | +$12.8M | ﹤0.01% | 1622 |
|
|
2024
Q1 | $2.46M | Sell |
28,838
-67,407
| -70% | -$5.29M | ﹤0.01% | 3767 |
|
|
2023
Q4 | $8.23M | Buy |
96,245
+71,973
| +297% | +$6.22M | ﹤0.01% | 2185 |
|
|
2023
Q3 | $2.17M | Buy |
24,272
+7,858
| +48% | +$702K | ﹤0.01% | 3912 |
|
|
2023
Q2 | $1.4M | Buy |
16,414
+6,441
| +65% | +$545K | ﹤0.01% | 4694 |
|
|
2023
Q1 | $825K | Sell |
9,973
-7,692
| -44% | -$623K | ﹤0.01% | 5378 |
|
|
2022
Q4 | $1.39M | Sell |
17,665
-11,793
| -40% | -$948K | ﹤0.01% | 4455 |
|
|
2022
Q3 | $2.18M | Buy |
29,458
+17,216
| +141% | +$1.24M | ﹤0.01% | 4063 |
|
|
2022
Q2 | $798K | Buy |
12,242
+894
| +8% | +$52.9K | ﹤0.01% | 5898 |
|
|
2022
Q1 | $717K | Sell |
11,348
-33,813
| -75% | -$1.84M | ﹤0.01% | 6802 |
|
|
2021
Q4 | $2.4M | Buy |
+45,161
| New | +$2.75M | ﹤0.01% | 4116 |
|
|
2021
Q3 | – | Sell |
-11,277
| Closed | -$712K | – | 10236 |
|
|
2021
Q2 | $752K | Buy |
11,277
+2,452
| +28% | +$174K | ﹤0.01% | 6446 |
|
|
2021
Q1 | $980K | Buy |
8,825
+6,815
| +339% | +$843K | ﹤0.01% | 5497 |
|
|
2020
Q4 | $239K | Sell |
2,010
-20,406
| -91% | -$2.2M | ﹤0.01% | 6732 |
|
|
2020
Q3 | $1.96M | Sell |
22,416
-302,323
| -93% | -$26.4M | ﹤0.01% | 3074 |
|
|
2020
Q2 | $29.1M | Buy |
324,739
+319,629
| +6,255% | +$32.3M | 0.02% | 561 |
|
|
2020
Q1 | $509K | Buy |
5,110
+2,081
| +69% | +$226K | ﹤0.01% | 3610 |
|
|
2019
Q4 | $348K | Sell |
3,029
-2,562
| -46% | -$310K | ﹤0.01% | 4112 |
|
|
2019
Q3 | $705K | Buy |
+5,591
| New | +$710K | ﹤0.01% | 3063 |
|
|
2019
Q2 | – | Sell |
-11,383
| Closed | -$996K | – | 5366 |
|
|
2019
Q1 | $996K | Buy |
+11,383
| New | +$1.04M | ﹤0.01% | 2816 |
|
|
2018
Q3 | – | Sell |
-92,075
| Closed | -$8.26M | – | 5337 |
|
|
2018
Q2 | $8.26M | Buy |
+92,075
| New | +$7.78M | 0.02% | 714 |
|
|
2017
Q3 | – | Sell |
-10,977
| Closed | -$433K | – | 4685 |
|
|
2017
Q2 | $433K | Buy |
+10,977
| New | +$451K | ﹤0.01% | 3206 |
|
|
2014
Q1 | – | Sell |
-5,268
| Closed | -$222K | – | 2831 |
|
|
2013
Q4 | $222K | Buy |
+5,268
| New | +$217K | ﹤0.01% | 1941 |
|
Other funds holding HAE
AI
Jane Street's HAE Position: Q2 2026 in Review
Jane Street sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 152,958 shares — an estimated $9.83M sold.
Jane Street first reported a position in HAE in Q4 2013 and held it in 30 quarters. The position peaked at $42.2M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Jane Street reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 152,958 Haemonetics shares in Q2 2026, an estimated $9.83M.
- Jane Street first reported a position in Haemonetics in Q4 2013 and held it in 30 quarters.
- Jane Street's Haemonetics position peaked at $42.2M in Q4 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.